TREK-1 is a background potassium channel, the protagonist in multiple key physiological functions and pathophysiological conditions in nervous and cardiovascular tissue including neuroprotection, depression, epilepsy, pain, ischemia, and atrial fibrillation (Djillani et al., 2019). This evidence concerns the gene KCNA3 and major depressive disorder.